🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚀 Excited to announce our latest Cell publication on "Cancer biomarkers: Emerging trends and clinical implications for personalized treatment." An important collaboration shedding light on promising avenues in cancer research.📑✨ sciencedirect.com/science/articl…

cell.com/cell-reports/f… Big milestone for my lab, separating functions of the BRCA pathway in reprogramming. Primary role is repair of the replication-associated DSB by HDR. More efficient HDR through 53BP1 loss improves reprogramming. This project took only 10 years! Congrats to

Registration is open for #EACR2024 at #Rotterdam Great line-up of speakers! Much to learn for the next-generation 😉. Find out more here: 2024.eacr.org EACR

Esta semana hemos sabido que identifican nuevos biomarcadores de imagen para predecir la respuesta al tratamiento en pacientes con cáncer de próstata con metástasis óseas 🗞️ Los resultados del estudio #iPROMET se han publicado en European Urology ➡️  linke.to/iPROMETCASTVHIO

📢One of the best annual events in Cancer Research is coming! Great speakers, excellent scientific content...get ready for the next EACR Congress! 📅Save the date: 10-13 June 2024 in Rotterdam! 👉Early Rate Registration: 29/04/24 👉Regular Rate Registration: 27/05/24

Sequential requirements for distinct Polθ domains during theta-mediated end joining dlvr.it/T5kL0F

📢Registrations are open for the #BarcelonaBiomed #Conference "Molecular Determinants of #Cancer Therapy Resistance"! 👉18-20 November, 2024 📍Casa Convalescència, #Barcelona ✅Organized by Dr. Ángel R. Nebreda (#IRBBarcelona), Dr. Clare Isacke (The ICR) & Dr. @m_malumbres

🌞 Fa poques hores s'ha confirmat l'arribada al nostre planeta de la tempesta geomagnètica més important dels darrers anys, produïda per una gran ejecció de massa coronal del Sol. I això és el que està provocant que es puguin veure aurores boreals ara mateix sobre Catalunya!

Dr. judith balmaña has presented our RADIOLA trial today in @ESMOBREAST24 in her lecture "Systemic therapy horizons for hereditary breast cancer beyond BRCA" #breastcancer #beSOLTI 🔗gruposolti.org/ensayosclinico… #beSOLTI #cancerdemama Vall d’Hebron Institute of Oncology (VHIO)

The lab 2024 article is out! BRCA1/BARD1 ubiquitinates PCNA to promote continuous, ssDNA-free, DNA synthesis in a RAD18-independent pathway. Congrats to all authors, specially to ⁦Daniel Salas Lloret⁩ & ⁦⁦Néstor García Rodríguez⁩ Cabimer Investigación US nature.com/articles/s4146…

Cancer Chemotherapy #meded #medx #chemotherapy #cancer #oncology OncoDaily @oncoalert

Now available #OpenAccess in Annals of Oncology, recommendations by the ESMO - Eur. Oncology Precision Medicine Working Group for the use of NGS for patients with advanced cancer in 2024 🧬Expanding indications 🧬CUP & tissue-agnostic situations 🧬Best practice annalsofoncology.org/article/S0923-…

Out now: H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours by Sven Rottenberg in Nature Communications #publicationoftheweek ➡️ bit.ly/4aFsiXK

Recommended reading 📚 A guide to artificial intelligence for cancer researchers by #CCE members Raquel Perez-Lopez  Vall d’Hebron Institute of Oncology (VHIO) and Jakob Nikolas Kather NCT Heidelberg published nature ➡️ shorturl.at/j68Ks #AI #CancerResearch #Imaging

📣 Pròxim #VHIOTalks2024‼️ 🔹Biomarcadors en #CàncerMama metastàtic i desenvolupament de noves estratègies terapèutiques 💬Amb Mafalda Oliveira, Violeta Serra i Sara Cervelló en un debat que moderarà @luisquevedo.bsky.social 🗓️20 de juny ⏰18 h 📍Portal de L'Eixample 👉linke.to/VHIOTalksBIOMA…

Wonderful to present our work on the new PARP1 selective inhibitor saruparib at the Annual Congress of the European Association of Cancer Research #EACR2024. Always great to hear fascinating talks and network with other researchers 🧬🇳🇱

🏆And again, after two Radiomics prizes at the 2023 edition in Valladolid, we are so proud that our beloved Olivia Prior Olivia Prior 🌸 won the 1st prize for the best oral presentation at the 2024 ISMRM Iberian Chapter Chapter in Porto! 🎊Congratulations Olivia, your work on #Habitats rocks!

New paper from the lab Vall d’Hebron Institute of Oncology (VHIO) is out in Cancer Cell: dual DNA/mRNA profiling from circulating EVs in #prostatecancer liquid biopsies Team-science work led by our own Irene cell.com/cancer-cell/fu…

💊 Un inhibidor selectiu de PARP1 mostra una potent i duradora activitat antitumoral en models preclínics derivats de pacients. 🗞️ Realitzat per professionals del VHIO i Vall d'Hebron, l’estudi s’ha publicat recentment a Genome Medicine ➕linke.to/PARP1PDXVHIcat

📣 Don't miss Violeta Serra presenting her poster on HRD biomarkers in #liquidbiopsy at #ESMO24 today from 12:00! 🕛 Exciting insights into ctDNA and circulating tumor cells analysis. #BreastCancer #TraslacionalVHIO